Navigation Links
Avion Pharmaceuticals, LLC., Launches Prenate Mini
Date:7/24/2012

ATLANTA, July 24, 2012 /PRNewswire/ -- Avion Pharmaceuticals, a specialty pharmaceutical company, announces the launch of Prenate Mini, the newest addition to the Prenate family of vitamins.  Prenate Mini is unique in its size and nutritional value, using the next generation folate – Quatefolic, DHA – and essential vitamins and minerals all in one easy-to-swallow gel cap.

"Avion is excited to offer women Prenate Mini as an option for potentially improved tolerability, making nutrition an easy part of prenatal care for women during pregnancy," said Mike Sullivan, Vice President, Sales and Marketing, for Avion Pharmaceuticals.  "Prenate Mini is the first of many innovative nutritional offerings that Avion will be offering women through our new Prenate Continuum of Care."

"We are extremely pleased about the launch of Prenate Mini as we continue to build upon our Prenate franchise, which will be launched by our national sales force," said Mark Pugh, Chief Executive Officer of Avion Pharmaceuticals.  "This is the first of many new product offerings that Avion will bring to market in women's health, further establishing our company as the premier women's health specialty pharmaceutical company in the U.S."

About Avion Pharmaceuticals, LLC.

Avion Pharmaceuticals, LLC., is a Specialty Pharmaceutical company formed to develop and market a portfolio of innovative pharmaceutical products in the Women's Heath and Dermatology therapeutic areas.  Avion Pharmaceuticals focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development drugs to fulfill unmet medical needs.  For additional information about Avion Pharmaceuticals please contact the company at 678-325-5188.


'/>"/>
SOURCE Avion Pharmaceuticals, LLC.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
2. AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
3. Acella Pharmaceuticals, LLC, files Abbreviated New Drug Application (ANDA) With the U.S. Food & Drug Administration for Topical Corticosteroids Lotion
4. Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
5. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
6. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
7. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
8. Hybrid Fuels, Inc. Announces Name Change to Nouveau Life Pharmaceuticals, Inc.
9. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
10. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
11. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... -- Non-invasive diagnostic test realizes the potential ... to be presented at Yissum’s booth, at IATI-BIOMED 2016 ... of the Hebrew University of Jerusalem announced today ... Ventures MKI, the technology investment arm of Morris Kahn ... for early detection of multiple diseases by analyzing circulating ...
(Date:5/22/2016)... May 23, 2016 DS ... anti-fibrotic and anti-inflammatory compound DS102 in chronic obstructive ... non-alcoholic steatohepatitis (NASH) patients. Recent DS ... in lung tissue and has bronchodilatory, anti-inflammatory and ... administration. The Company will publish further detail on ...
(Date:5/20/2016)... , May 20, 2016 ... Pipeline Review, H1 2016" market research report with ... Psoriasis (Psoriasis Vulgaris), complete with comparative analysis at ... of action (MoA), route of administration (RoA) and ... news and press releases. It also reviews key ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... Fire ... to provide one resource, from start to finish, for Life Safety compliance. ... of Condition surveys requested by the Joint Commission, and fire stopping reviews, inspections, ...
(Date:5/24/2016)... ... May 24, 2016 , ... United Benefit ... welcome new Partner Firm Austin & Co., Inc. Headquartered in Albany, New ... benefits, HR consulting, benefits technology, and beyond. As an employee-owned company celebrating ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... How to ... · Raleigh, NC, http://www.fdanews.com/humanerrordrugdevice , Human error is known to be the ... that human error will ever be totally eliminated, many human performance problems can be ...
(Date:5/24/2016)... Irvine, CA — , ... ... the appointment of three new members of its Advisory Board. ... Chico and Sarah Kusch. “All three of them embody the mission ... team. We are very fortunate to have them as we continue ...
(Date:5/24/2016)... ... 24, 2016 , ... Backed by decades of experience, Metroloji ... ensuring the best suited solution to meet regulatory requirements. Their professional staff also ... in Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical and pharmaceutical ...
Breaking Medicine News(10 mins):